Nebius Group N.V. has achieved over 400% year-over-year sales growth, reaching a $3 billion run rate and driving a tenfold increase in its share price within two years. The company maintains strong EBITDA margins of 40% and manages its balance sheet conservatively, with limited operating leases and net debt around $500 million. Despite a high valuation of 28–33 times sales and rising GAAP losses, Nebius benefits from a $40 billion backlog, lucrative contracts, and aggressive capacity expansion. Its rapid growth, pricing power, and disciplined capital management position it as a key player to watch in the sector.
Nvidia updated its stock portfolio to $63.4 billion as of June 30, 2026, a sharp rise from $18.4 billion the previous quarter. This growth was driven by gains in existing holdings and a new $21 billion position in SpaceX, marking Nvidia's first publi...
Nebius Group conducted its first capacity auction this quarter, achieving prices 15% above its previous highs and 20% above internal quotes for Blackwell chips. The company reported a 454% year-over-year revenue increase and a 598% rise in annual rec...
Anthropic, an AI company, is targeting an October IPO with a valuation of $2 trillion or more, which would surpass SpaceX's recent $1.77 trillion debut. Investors expect the company's revenue to jump from $47 billion to over $100 billion within a yea...
Equity markets continue to rise driven by optimism around AI, with companies like CoreWeave and Nebius posting strong quarterly results. However, credit markets are showing signs of increasing stress, particularly in private credit and commercial rea...
President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...
